This groundbreaking study, funded by a $2.78 million grant from the National Institutes of Health and National Cancer Institute, brings together researchers from Case Western Reserve University, Cleveland Clinic, and University Hospitals to harness the power of artificial intelligence (AI) in revolutionizing the treatment of rectal cancer patients. With rectal cancer being the third most common type of cancer in the digestive system, this research aims to develop new radiomic signatures using AI-driven analysis of medical images to accurately determine how well patients respond to therapy. By doing so, clinicians will be able to personalize treatments, reducing unnecessary surgeries and associated complications. The study’s innovative approach has the potential to bring significant survival and quality-of-life benefits to rectal cancer patients, marking a major step forward in cancer care. The collaboration between medical institutions and disciplines is a testament to the power of interdisciplinary research in driving meaningful change.
AI-Powered Cancer Care
Researchers will analyze medical images from over 900 rectal cancer patients using AI to develop a non-invasive and accurate method to identify patients with no tumor remaining after therapy.
1–2 minutes
TOP STORIES
Unauthorized users have gained access to Anthropic’s Mythos, raising security concerns …
Clarifai has deleted millions of photos from OkCupid amid an FTC investigation into data misuse …
Nvidia’s Vera Rubin platform is set to revolutionize AI inference with unmatched performance …
Apple’s leadership transition highlights a strategic focus on silicon for AI innovation …
Apple’s leadership changes signal a strategic shift towards AI and silicon innovation …
Tennessee’s new law restricts AI claims in mental health but may create loopholes …
